Genetic derangements in the tumor suppressor gene PTEN in endometrial precancers as prognostic markers for cancer development: A population-based study from northern Norway with long-term follow-up

Gynecologic Oncology

Volumn 95, Issue 1, 2004, Pages 82-88

  Orbo A ^a   Kaino, T ^a   Arnes, M ^a   Kopp, M ^b   Eklo, K ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Genetic derangements; Norway; PTEN

Indexed keywords

AMINO ACID; MARKER; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; DNA SEQUENCE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; EXON; FEMALE; FOLLOW UP; FRAMESHIFT MUTATION; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NORWAY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARRIER PROTEINS; DNA, NEOPLASM; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROGNOSIS; PTEN PHOSPHOHYDROLASE; TUMOR SUPPRESSOR PROTEINS;

EID: 4644236401     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.07.024     Document Type: Article

References (31)

1. R.J. Barrett II, L.C. Harlan, M.N. Wesley, H.A. Hill, V.W. Chen, and L.A. Clayton Endometrial cancer: stage at diagnosis and associated factors in black and white patients Am. J. Obstet. Gynecol. 173 1995 414 422
2. R.J. Kurman, P.F. Kaminski, and H.J. Norris The behaviour of endometrial hyperplasia. A long-term study of "untreated " hyperplasia in 170 patients Cancer 6 1985 403 412
3. H. Tashiro, M.S. Blazes, R. Wu, K.R. Cho, S. Bose, S. Wang, and J. Li Mutations in PTEN are frequent in endometrial carcinoma but rare in other gynecological malignancies Cancer Res. 57 18 1997 3935 3940
4. J.I. Risinger, A.K. Hayes, A. Berchuck, and J.C. Barrett PTEN/MMAC1 mutations in endometrial cancers Cancer Res. 57 21 1997 4736 4738
5. G. Mutter, M-C. Lin, J.T. Fitzgerald, J.B. Kum, J.P.A. Baak, and J.A. Lees Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers J. Natl. Cancer Inst. 92 2000 924 931
6. T. Imamura, T. Arima, H. Kato, S. Miyamoto, T. Sasazuki, and N. Wake Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas Int. J. Cancer 51 1992 47 52
7. T. Enomoto, M. Fujita, M. Inoue, T. Nomura, and K.R. Shroyer Alteration of the p53 tumor suppressor gene and activation off c-K-ras 2 protooncogene in endometrial adenocarcinoma from Colorado Am. J. Clin. Pathol. 103 1995 224 230
8. J.I. Risinger, G.A. Dent, D. Ignar-Trowbridge, J.A. McLachlan, M.S. Tsao, and M. Senterman p53 gene mutations in human endometrial carcinoma Mol. Carcinog. 5 4 1992 2503
9. R.T. Burks, T.D. Kessis, K.R. Cho, and L. Hedrick Microsatellite instability in endometrial carcinoma Oncogene 9 1994 1163 1166
10. B.D. Duggan, J.C. Felix, L.I. Muderspach, D. Tourgeman, J. Zheng, and D. Shibata Microsatellite instability in sporadic endometrial cancer J. Natl. Cancer Inst. 86 16 1994 1216 1221
11. J.I. Risinger, A. Berchuck, M.F. Kohler, P. Watson, H.T. Lynch, and J. Boyd Genetic instability of microsatellites in endometrial carcinoma Cancer Res. 53 21 1993 5100 5103
12. W.C. Faquin, J.T. Fitzgerald, K.A. Boynton, M.G. Muto, and G.L. Mutter Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues Am. J. Clin. Pathol. 113 4 2000 576 582
13. X. Matias-Guiu, L. Catasus, E. Bussaglia, H. Lagarda, A. Garcia, and C. Pons Molecular pathology of endometrial hyperplasia and carcinoma Hum. Pathol. 32 6 2001 569 577
14. G.L. Maxwell, J.I. Risinger, C. Gumbs, H. Shaw, R.C. Bentley, and J.C. Barrett Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias Cancer Res. 58 12 1998 2500 2503
15. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, and S.I. Wang PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
16. A. Di Cristofano, and P.P. Pandolfi The multiple roles of PTEN in tumor suppression Cell 100 4 2000 387 390
17. H. Sun, T. Enomoto, M. Fujita, H. Wada, K. Yoshino, and K. Ozaki Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia Am. J. Clin. Pathol. 115 1 2001 32 38
18. A. Ørbo, M.N. Nilsen, M.S. Arnes, I. Pettersen, and K. Larsen Expression of MLH1, MSH2, MSH6 and PTEN related to cancer development or coexistent cancer in 68 patients with endometrial hyperplasia and known follow-up Int. J. Gynecol. Pathol. 22 2003 141 148
19. A. Ørbo, J.P.A. Baak, I. Kleivan, S. Lysne, P.S. Prytz, and M.A. Broeckaert Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from northern Norway J. Clin. Pathol. 53 9 2000 697 703
20. J.P. Baak, J.J. Nauta, E.C. Wisse-Brekelmans, and P.D. Bezemer Architectural and nuclear morphometrical features together are more important prognosticators in endometrial hyperplasia than nuclear morphometrical features alone J. Pathol. 154 4 1988 335 341
21. J.P.A. Baak, A. Ørbo, P.J. Diest, M. Jiwa, P. de Bruin, and M. Broeckaert Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasia Am. J. Surg. Pathol. 25 7 2001 930 935
22. S.G. Silverberg, R.J. Kurman, F. Nogales, G.L. Mutter, R.A. Kubik-Huch, and F.A. Tavassoli Epithelial tumours and related lesions F.A. Tavasolli P. Devilee World Health Organization classification of tumours. Pathology and genetics. Tumours of the breast and female genital organs 2003 IARC Press Lyon 232
23. R.L. Levine, C.B. Cargile, M.S. Blazes, B. van Rees, R.J. Kurman, and L.H. Ellenson PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma Cancer Res. 58 1998 3254 3258
24. B. Konopka, Z. Paszko, A. Janiec-Jankowska, and M. Goluda Assessment of the quality and frequency of mutations occurrence in endometrial carcinoma and hyperplasias Cancer Lett. 178 1 2002 43 51
25. H. Tashiro, M.S. Blazes, K.R. Cho, S. Bose, S.I. Wans, and J. Li Mutations in PTEN are frequent in endometrial cancer but rare in other common gynecological malignancies Cancer Res. 57 1997 3935 3940
26. T. Minaguchi, H. Yoshikawa, K. Oda, T. Ishino, T. Yasugi, and T. Onda PTEN mutation located only outside exons 5, 6 and 7 is an independent predictor of favourable survival in endometrical carcinomas Clin Cancer Res. 7 2001 2636 2642
27. J.O. Lee, H. Yang, M.M. Georgescu, A. Di Cristofano, T. Machama, and Y. Shi Crystal structure of the PTEN tumor suppressor; implications for its phosphoinositide phosphatase activity and membrane association Cell 99 1999 323 324
28. I.U. Ali, L.M. Schriml, and M. Dean Mutational spectra of PTEN/MMAC1gene: a tumor suppressor with lipid phosphatase activity J. Natl. Cancer Inst. (Bethesta) 91 1999 1922 1932
29. M. Esteller, L. Catasus, X. Matias-Guiu, G.L. Mutter, J. Prat, and S.B. Baylin hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis Am. J. Pathol. 155 5 1999 1767 1772
30. H.B. Salvesen, N. MacDonald, A. Ryan, I.J. Jacobs, E.D. Lynch, and L.A. Akslen PTEN methylations associated with advanced stage and microsatellite instability in endometrial carcinoma Int. J. Cancer 91 2001 22 26
31. G.L. Mutter, T.A. Ince, J.P.A. Baak, G.A. Kust, X.P. Zhou, and C. Eng Molecular identification of latent precancers in histologically normal endometrium Cancer Res. 61 2001 4311 4314